back to Meetings page
  • IMMPACT-XXI
  • July 26-27, 2018
  • Westin City Center
  • Washington, DC

  • Co-chairs:
  • Robert H. Dworkin, PhD (University of Rochester)
  • Dennis C. Turk, PhD (University of Washington)
  • Academia and Related Participants
  • Robert Edwards, PhD (Harvard Medical School)
  • James Eisenach, MD (Wake Forest School of Medicine)
  • John T. Farrar, MD, PhD (University of Pennsylvania)
  • Howard Fields, MD, PhD (University of California San Francisco)
  • Roy Freeman, MD (Harvard Medical School)
  • Tong Joo (TJ) Gan, MD (Stony Brook School of Medicine)
  • Jennifer S. Gewandter, PhD (University of Rochester)
  • Ian Gilron, MD (Queen's University)
  • Hanna Grol-Prokopczyk, PhD (University of Buffalo)
  • Jennifer Haythornthwaite, PhD (Johns Hopkins University School of Medicine)
  • Robert Jamison, PhD (Harvard Medical School)
  • Nathaniel Katz, MD (Analgesic Solutions and Tufts University)
  • Kurt Kroenke, MD (Indiana University School of Medicine)
  • John D. Markman, MD (University of Rochester)
  • Marc Martel, PhD (McGill University)
  • Ewan McNicol, PharmD (Tufts University School of Medicine)
  • Srinivasa Raja, MD (Johns Hopkins University School of Medicine)
  • James Rathmell, MD (Harvard Medical School)
  • Richard Rauck, MD (Carolinas Pain Institute)
  • Michael Rowbotham, MD (California Pacific Medical Center Research Institute)
  • Lee S. Simon, MD (SDG Consulting)
  • Shannon M. Smith, PhD (University of Rochester)
  • Brett Stacey, MD (University of Washington)
  • Eric Strain, MD (Johns Hopkins University School of Medicine)
  • Denham Ward, MD, PhD (University of Rochester)
  • Ajay Wasan, MD (University of Pittsburgh)
  • Government Participants
  • Inna Belfer, MD, PhD (National Institutes of Health Office of Research on Women's Health)
  • Jeremy Brown, MD (National Institute of Neurological Disorders and Stroke)
  • Allan Chiu, MD (Food and Drug Administration)
  • Sharon Hertz, MD (Food and Drug Administration)
  • Jonathan Jarow, MD (Food and Drug Administration)
  • Allison Lin, PharmD, PhD (Food and Drug Administration)
  • Joshua Lloyd, MD (Food and Drug Administration)
  • Janet Maynard, MD (Food and Drug Administration)
  • David McCann, PhD (National Institute of Drug Abuse)
  • Michael Oshinsky, PhD (National Institute of Neurological Disorders and Stroke)
  • Carlos Pena, PhD (Food and Drug Administration)
  • Kurt Rasmussen, PhD (National Institute of Drug Abuse)
  • Friedhelm Sandbrink, MD (Veterans Health Administration)
  • Erika Torjusen, MD (Food and Drug Administration)
  • Martha van Clief, MD (Food and Drug Administration)
  • Patient Representatives
  • Penney Cowan (American Chronic Pain Association)
  • Industry Participants
  • Colville Brown, MD (Innocoll)
  • Kevin Craig, MD (GW Pharma)
  • Kathryn Giblin, MD (Biogen)
  • Torsten Madsen, MD, PhD (Aptinyx)
  • Joachim Scholz, MD (Biogen)
  • Richard Scranton, MD (Pacira)
  • Deb Steiner, MD (Sarepta)
  • Kenneth Verburg, PhD (Pfizer)
  • Kerry Wentworth (Flexion)